Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Iridex Cp (IRIX)
Iridex Cp (IRIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 44,519
  • Shares Outstanding, K 16,248
  • Annual Sales, $ 56,970 K
  • Annual Income, $ -7,550 K
  • 60-Month Beta 0.75
  • Price/Sales 0.77
  • Price/Cash Flow N/A
  • Price/Book 3.70
Trade IRIX with:

Options Overview Details

View History
  • Implied Volatility 105.95% ( +9.24%)
  • Historical Volatility 147.13%
  • IV Percentile 45%
  • IV Rank 12.29%
  • IV High 693.34% on 08/17/23
  • IV Low 23.62% on 10/16/23
  • Put/Call Vol Ratio 999.99
  • Today's Volume 1
  • Volume Avg (30-Day) 58
  • Put/Call OI Ratio 0.38
  • Today's Open Interest 4,058
  • Open Int (30-Day) 4,007

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate -0.09
  • Number of Estimates 2
  • High Estimate -0.05
  • Low Estimate -0.12
  • Prior Year -0.07
  • Growth Rate Est. (year over year) -28.57%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.89 +44.97%
on 11/14/23
2.85 -3.87%
on 12/05/23
+0.54 (+24.55%)
since 11/08/23
3-Month
1.63 +68.10%
on 11/01/23
3.48 -21.26%
on 10/31/23
+0.86 (+45.74%)
since 09/08/23
52-Week
1.31 +109.10%
on 08/17/23
3.48 -21.26%
on 10/31/23
+0.57 (+26.27%)
since 12/08/22

Most Recent Stories

More News
Iridex: Q3 Earnings Snapshot

Iridex: Q3 Earnings Snapshot

IRIX : 2.74 (unch)
Iridex: Q2 Earnings Snapshot

Iridex: Q2 Earnings Snapshot

IRIX : 2.74 (unch)
Iridex: Q1 Earnings Snapshot

Iridex: Q1 Earnings Snapshot

IRIX : 2.74 (unch)
Lumentum (LITE) Q3 Earnings and Revenues Lag Estimates

Lumentum (LITE) delivered earnings and revenue surprises of -9.64% and 2.46%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

LITE : 43.70 (+0.34%)
IRIX : 2.74 (unch)
Iridex (IRIX) Reports Q4 Loss, Tops Revenue Estimates

Iridex (IRIX) delivered earnings and revenue surprises of 36.36% and 0.20%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

IRIX : 2.74 (unch)
CXDO : 3.15 (+1.61%)
Iridex: Q4 Earnings Snapshot

Iridex: Q4 Earnings Snapshot

IRIX : 2.74 (unch)
Agilent Technologies (A) Surpasses Q1 Earnings and Revenue Estimates

Agilent (A) delivered earnings and revenue surprises of 4.58% and 3.78%, respectively, for the quarter ended January 2023. Do the numbers hold clues to what lies ahead for the stock?

A : 127.81 (-0.68%)
IRIX : 2.74 (unch)
IPG Photonics (IPGP) Reports Q4 Loss, Tops Revenue Estimates

IPG (IPGP) delivered earnings and revenue surprises of -309.89% and 5.72%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

IPGP : 99.32 (-0.68%)
IRIX : 2.74 (unch)
Iridex (IRIX) Reports Q3 Loss, Tops Revenue Estimates

Iridex (IRIX) delivered earnings and revenue surprises of 26.67% and 5.55%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

IRIX : 2.74 (unch)
ADSK : 224.29 (+0.20%)
Iridex: Q3 Earnings Snapshot

Iridex: Q3 Earnings Snapshot

IRIX : 2.74 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

IRIDEX Corporation is the leading worldwide provider of semiconductor-based laser systems used to treat eye diseases in ophthalmology and skin lesions in dermatology. The products are sold in the United States predominantly through a direct sales force and internationally through independent distributors....

See More

Key Turning Points

3rd Resistance Point 2.86
2nd Resistance Point 2.81
1st Resistance Point 2.78
Last Price 2.74
1st Support Level 2.69
2nd Support Level 2.64
3rd Support Level 2.61

See More

52-Week High 3.48
Last Price 2.74
Fibonacci 61.8% 2.65
Fibonacci 50% 2.40
Fibonacci 38.2% 2.14
52-Week Low 1.31

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar